Recce Pharmaceuticals Halts Trading Ahead of Capital Raise
Key points
- Trading halt requested by Recce Pharmaceuticals
- Halt in effect until June 26, 2026 or announcement release
- Halt due to pending announcement on proposed equity capital raise
- No reason for halt refusal or additional market information
Full summary
Recce Pharmaceuticals Ltd (ASX: RCE) has requested a trading halt on its securities as per ASX Listing Rule 17.1, pending the release of an announcement relating to a proposed equity capital raise. The halt will be effective immediately and remain in place until the earlier of the commencement of normal trading on Friday, June 26, 2026, or the release of the announcement. The company is not aware of any reason why the trading halt should not be granted nor any other information necessary to inform the market about the trading halt.
Summary generated by a large language model. Please interpret with care.